151 related articles for article (PubMed ID: 21148302)
1. Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of congenital adrenal hyperplasia.
Cantürk C; Baade U; Salazar R; Storm N; Pörtner R; Höppner W
Clin Chem; 2011 Mar; 57(3):511-7. PubMed ID: 21148302
[TBL] [Abstract][Full Text] [Related]
2. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.
Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB
Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666
[TBL] [Abstract][Full Text] [Related]
3. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
[TBL] [Abstract][Full Text] [Related]
4. Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia.
Lee HH
Clin Chim Acta; 2013 Mar; 418():37-44. PubMed ID: 23313747
[TBL] [Abstract][Full Text] [Related]
5. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the CYP21A1P pseudogene: indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes.
Tsai LP; Cheng CF; Chuang SH; Lee HH
Anal Biochem; 2011 Jun; 413(2):133-41. PubMed ID: 21324303
[TBL] [Abstract][Full Text] [Related]
7. Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia.
Vrzalová Z; Hrubá Z; Hrabincová ES; Vrábelová S; Votava F; Koloušková S; Fajkusová L
Eur J Med Genet; 2011; 54(2):112-7. PubMed ID: 20970527
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
9. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics.
Concolino P; Mello E; Minucci A; Zuppi C; Capoluongo E
Clin Chem; 2011 Jul; 57(7):1079-80. PubMed ID: 21507910
[No Abstract] [Full Text] [Related]
10. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
Lee HH; Tsai FJ; Lee YJ; Yang YC
Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of CYP21A2 gene and CYP21A1P pseudogene: long-range PCR on genomic DNA.
Lee HH
Methods Mol Biol; 2014; 1167():275-87. PubMed ID: 24823785
[TBL] [Abstract][Full Text] [Related]
12. Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia.
Tsai LP; Cheng CF; Hsieh JP; Teng MS; Lee HH
Clin Chim Acta; 2009 Dec; 410(1-2):48-53. PubMed ID: 19778530
[TBL] [Abstract][Full Text] [Related]
13. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
[TBL] [Abstract][Full Text] [Related]
14. High-resolution melting curve (HRM) analysis to establish CYP21A2 mutations converted from the CYP21A1P in congenital adrenal hyperplasia.
Lin YC; Lin YC; Liu TC; Chang JG; Lee HH
Clin Chim Acta; 2011 Oct; 412(21-22):1918-23. PubMed ID: 21762683
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
Xu Z; Chen W; Merke DP; McDonnell NB
J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
[TBL] [Abstract][Full Text] [Related]
16. A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency.
Parajes S; Quinterio C; Domínguez F; Loidi L
Clin Chem; 2007 Sep; 53(9):1577-84. PubMed ID: 17634211
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
[TBL] [Abstract][Full Text] [Related]
18. Long-read sequencing: An effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia.
Li H; Zhu X; Yang Y; Wang W; Mao A; Li J; Bao S; Li J
Clin Chim Acta; 2023 Jul; 547():117419. PubMed ID: 37276943
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency.
Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z
Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005
[TBL] [Abstract][Full Text] [Related]
20. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
Concolino P; Mello E; Toscano V; Ameglio F; Zuppi C; Capoluongo E
Clin Chim Acta; 2009 Apr; 402(1-2):164-70. PubMed ID: 19263525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
